BlackRock’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-109,531
| Closed | -$8.89K | – | 5839 |
|
|
2022
Q4 | $8.89K | Sell |
109,531
-2,220
| -2% | -$282 | ﹤0.01% | 5476 |
|
|
2022
Q3 | $14K | Sell |
111,751
-3,444
| -3% | -$725 | ﹤0.01% | 5563 |
|
|
2022
Q2 | $32K | Buy |
115,195
+56,664
| +97% | +$14.7K | ﹤0.01% | 5493 |
|
|
2022
Q1 | $18K | Sell |
58,531
-2,745
| -4% | -$2.94K | ﹤0.01% | 5580 |
|
|
2021
Q4 | $140K | Buy |
61,276
+42,030
| +218% | +$124K | ﹤0.01% | 5183 |
|
|
2021
Q3 | $44K | Buy |
19,246
+239
| +1% | +$906 | ﹤0.01% | 5295 |
|
|
2021
Q2 | $104K | Buy |
19,007
+18,266
| +2,465% | +$98.3K | ﹤0.01% | 5038 |
|
|
2021
Q1 | $4K | Hold |
741
| – | – | ﹤0.01% | 5165 |
|
|
2020
Q4 | $3K | Hold |
741
| – | – | ﹤0.01% | 4973 |
|
|
2020
Q3 | $1K | Hold |
741
| – | – | ﹤0.01% | 5027 |
|
|
2020
Q2 | $2K | Hold |
741
| – | – | ﹤0.01% | 4928 |
|
|
2020
Q1 | $1K | Hold |
741
| – | – | ﹤0.01% | 4938 |
|
|
2019
Q4 | $0 | Hold |
741
| – | – | ﹤0.01% | 5111 |
|
|
2019
Q3 | $1K | Sell |
741
-3,654
| -83% | -$4.92K | ﹤0.01% | 4958 |
|
|
2019
Q2 | $6K | Sell |
4,395
-9,234
| -68% | -$14.3K | ﹤0.01% | 4815 |
|
|
2019
Q1 | $23K | Sell |
13,629
-896
| -6% | -$1.32K | ﹤0.01% | 4578 |
|
|
2018
Q4 | $15K | Sell |
14,525
-256
| -2% | -$442 | ﹤0.01% | 4618 |
|
|
2018
Q3 | $30K | Buy |
14,781
+576
| +4% | +$1.24K | ﹤0.01% | 4605 |
|
|
2018
Q2 | $35K | Buy |
14,205
+2,548
| +22% | +$7.09K | ﹤0.01% | 4602 |
|
|
2018
Q1 | $35K | Sell |
11,657
-3,075
| -21% | -$10.8K | ﹤0.01% | 4492 |
|
|
2017
Q4 | $59K | Buy |
14,732
+440
| +3% | +$1.34K | ﹤0.01% | 4414 |
|
|
2017
Q3 | $50K | Sell |
14,292
-605
| -4% | -$1.71K | ﹤0.01% | 4478 |
|
|
2017
Q2 | $43K | Buy |
14,897
+11,356
| +321% | +$37.1K | ﹤0.01% | 4550 |
|
|
2017
Q1 | $5K | Buy |
+3,541
| New | +$5.88K | ﹤0.01% | 4797 |
|
Other funds holding STAB
BlackRock's STAB Position: Q1 2023 in Review
BlackRock sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2023, closing a stake of 109,531 shares — an estimated $8.89K sold.
BlackRock first reported a position in STAB in Q1 2017 and held it in 24 quarters. The position peaked at $140K in Q4 2021. 4 funds tracked by Wall St. Rank hold STAB as of Q1 2023.
- BlackRock reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- BlackRock sold 109,531 Statera Biopharma, Inc. Common Stock shares in Q1 2023, an estimated $8.89K.
- BlackRock first reported a position in Statera Biopharma, Inc. Common Stock in Q1 2017 and held it in 24 quarters.
- BlackRock's Statera Biopharma, Inc. Common Stock position peaked at $140K in Q4 2021.
- 4 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2023.
Based on BlackRock's 13F filing for Q1 2023, filed 12 May 2023.